Citius Pharmaceuticals
CTXR | NASDAQ
$0.54
$0.00 (+0.92%)
At close: Nov 16, 2026, 3:59 PM ET
$0.53
-$0.01 (-1.87%)
After-hours:
Nov 16, 2026, 7:53 PM ET
+0.92%
(1D)No price chart data available for 1D timeframe.
Rating
47
Fundamentals Average
Market Sentiment Neutral
Moat None
Sector Rank #346/1021 (Top 34%)
Key Statistics
Market Data
Market Cap $14.81M
1D Range
0.50 0.55
52W Range
0.37 1.44
Valuation (TTM)
PE -0.26
PB 0.22
EV/EBITDA -0.09
Valuation (NTM)
Forward PE 0.65
Forward PEG 0.01
Price Target $6.00
Cash Flow
FCF Yield -235.5%
SBC Adj. FCF Yield -309.5%
SBC Impact -31.4%
Margins
Gross Margin 20.0%
Operating Margin -863.9%
FCF Margin -490.7%
Growth (CAGR)
Revenue 3Y | 5Y 150.0% |
100.0%
Dil EPS 3Y | 5Y 31.8% |
-18.7%
FCF 3Y | 5Y -10.3% |
20.3%
Returns
ROA -32.5%
ROE -67.2%
ROIC -67.6%
Financial Health
Net Cash
$9.83M
Current Ratio 0.84
Interest Coverage -88.28
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
Citius Pharmaceuticals, Inc. operates as a specialized pharmaceutical firm concentrating on the development and market introduction of critical care products. Its efforts are particularly directed tow...
Sector Healthcare
Industry Biotechnology
Employees 23
IPO Date Oct 2, 2014
Website www.citiuspharma.com
Fiscal Year October - September
Latest News
No news articles available yet.
Analyst Summary
# of Analysts
1
Consensus
Buy
Price Target
$6.00
Upside
+1011.11%
Buy (1)
Hold (0)
Sell (0)
Add to Watchlist
Select watchlists to add or remove CTXR